Macromolecular anticancer agent, PEGylated Zinc protoporphyrin (ZnP) targeting HSP32

靶向HSP32的高分子抗​​癌剂聚乙二醇化锌原卟啉(ZnP)

基本信息

  • 批准号:
    20015045
  • 负责人:
  • 金额:
    $ 6.08万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2008
  • 资助国家:
    日本
  • 起止时间:
    2008 至 2009
  • 项目状态:
    已结题

项目摘要

We prepared two types of polymeric drugs having anti-HO-1 and antitumor activities, (i) PEGylated ZnPP (covalently linked ) and (ii) SMA-ZnPP micelles. Cell uptake was several fold faster in SMA-ZnPP micelles than PEG-ZnPP conjugates. They exhibited both in vitro cytotoxicity and in vivo antitumor activity having IC_<50> of 1-7μM and 10mg/kg in vivo respectively. They also exhibited enhanced cytotoxicity to human tumor cells (CML cell line, K562 ; ATL cell line, MT-2 ; esophageal cell line, Kyse 510) in culture under the exposure to LED light at 420nm. Mouse tumors were more effectively suppressed with SMA-ZnPP plus LED light at 420nm than drug alone both in vivo and in vitro. PEG-ZnPP conjugates (covalent) undergo hydrolytic cleavage by serine and thiol proteases in the tumor tissue and released free ZnPP, whereas SMA-ZnPP micelles underwent micelle disintegration upon the contact with to cell membrane components such as lecithin, and released the drug ZnPP effectively in cells.
我们准备了具有抗HO-1和抗肿瘤活性的两种类型的聚合物药物:(i)Pegypated Znpp(共价连接)和(ii)SMA-ZNPP胶束。在SMA-ZNPP胶束中,细胞摄取比PEG-ZNPP结合物快几倍。他们分别在体外暴露了体外细胞毒性和体内抗肿瘤活性,分别为1-7μm和10mg/kg体内。他们还向人类肿瘤细胞(CML细胞系,K562; ATL细胞系,MT-2;食管510,KYSE 510)暴露了增强的细胞毒性,在420nm的LED光线下培养。与单独的体内和体外药物相比,SMA-ZNPP和LED光在420nm处更有效地抑制了小鼠肿瘤。 PEG-ZNPP结合物(共价)在肿瘤组织中通过丝氨酸和硫醇蛋白酶进行水解裂解,并释放自由ZNPP,而SMA-Znpp胶束在与细胞膜成分接触时经历了胶束分解,例如细胞膜成分,例如Lecithin,并释放出卵裂蛋白,并释放出药物ZNPPP的细胞,并有效地在Prunpppp中。

项目成果

期刊论文数量(89)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
高分子薬剤のEPR効果による腫瘍デリバリーと癌治療
利用聚合物药物的 EPR 效应进行肿瘤递送和癌症治疗
Immunostimulation-mediated antitumor activity by preconditioning with rice-shochu distillation residue against implanted tumor in mice.
用大米烧酒蒸馏残渣预处理对小鼠植入肿瘤的免疫刺激介导的抗肿瘤活性。
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Seki;et al;H. Maeda(6/7番目);K. Kida
  • 通讯作者:
    K. Kida
Current problems in cancer chemotherapy and new developments toward more cancer selective drug targeting based on EPR-effect
癌症化疗的当前问题以及基于 EPR 效应的更多癌症选择性药物靶向的新进展
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    大場岳彦;中村裕;右田敏郎;奥村栄;矢守隆夫;石川雄一;清宮啓之;H. Maeda
  • 通讯作者:
    H. Maeda
Tumor selective targeting using macromolecular drugs based on EPR effect: Future solutions for solid tumor chemotherapy
基于EPR效应的大分子药物肿瘤选择性靶向:实体瘤化疗的未来解决方案
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Seimiya;H.;Ohishi;T.;Tsuruo;T.;H. Maeda
  • 通讯作者:
    H. Maeda
Tumor selective targeting using macromolecular drugs based on EPR effect : Future solutions for solid tumor chemotherapy
基于EPR效应的大分子药物肿瘤选择性靶向:实体瘤化疗的未来解决方案
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    川谷誠;青野晴美;矢守隆夫;長田裕之;清宮啓之;前田浩
  • 通讯作者:
    前田浩
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAEDA Hiroshi其他文献

MAEDA Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAEDA Hiroshi', 18)}}的其他基金

Growth inhibition of selected bacterial species by peptide nucleic acids for control of oral microflora
通过肽核酸抑制选定细菌种类的生长以控制口腔微生物区系
  • 批准号:
    15K11404
  • 财政年份:
    2015
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of antisense PNA as antibiotics against periodontal pathogens
反义PNA作为牙周病原菌抗生素的应用
  • 批准号:
    24659925
  • 财政年份:
    2012
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Influence to a wrist joint by the topspin technology in tennis
网球上旋技术对腕关节的影响
  • 批准号:
    23500739
  • 财政年份:
    2011
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cross reactivity of archaeal chaperonin with human CCT involved in the pathogenesis of periodontitis and autoimmune disease
古菌伴侣蛋白与人类 CCT 的交叉反应参与牙周炎和自身免疫性疾病的发病机制
  • 批准号:
    21592624
  • 财政年份:
    2009
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New miceller agent for antioxidation therapy based on XO inhibition using AHPP
基于 AHPP 的 XO 抑制的新型抗氧化治疗胶束剂
  • 批准号:
    20590049
  • 财政年份:
    2008
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular cloning and functional analysis of non-coding RNA expressed in periodontal bacteria
牙周细菌表达非编码RNA的分子克隆及功能分析
  • 批准号:
    19592387
  • 财政年份:
    2007
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The effect on human body at the impact of tennis racket and balls from the viewpoints of mechanical characteristics of the grip
从握把力学特性看网球拍与球撞击时对人体的影响
  • 批准号:
    16500415
  • 财政年份:
    2004
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A High-Precision and High-Speed Stereo Matching Algorithm Based on Synergetics and its Application to Automatic Production of Rough 3 D City Area Map
基于协同学的高精度高速立体匹配算法及其在城市三维粗图自动制作中的应用
  • 批准号:
    16500133
  • 财政年份:
    2004
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control of Nanoscale Structures of Amphiphilic Self-Assembly by Physical Factors
物理因素对两亲性自组装纳米结构的控制
  • 批准号:
    12440200
  • 财政年份:
    2000
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on the role of NO in microbial pathogenesis
NO在微生物发病机制中的作用研究
  • 批准号:
    12470065
  • 财政年份:
    2000
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

The pathophysiology of malignant glioma and treatment strategies
恶性胶质瘤的病理生理学和治疗策略
  • 批准号:
    17390404
  • 财政年份:
    2005
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Involvement of VEGF receptors or inflammatory cytokines in tumor angiogenesis as a cancer therapy
VEGF 受体或炎症细胞因子参与肿瘤血管生成作为癌症治疗
  • 批准号:
    10557014
  • 财政年份:
    1999
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了